Charles Barkley, a celebrated NBA icon, has evolved into a prominent figure during the NCAA Tournament each March, known for his humorous commentary and candid reactions. This year, however, fans have taken notice of a noticeable change in his physique—Barkley appears significantly leaner than in recent years. Barkley has openly discussed his weight-loss journey, revealing that he shed 62 pounds since 2023. He attributed this transformation to a weekly injection of Mounjaro, a medication containing tirzepatide, alongside regular physical activity. He emphasized that the drug helped regulate his appetite and improve long-standing habits, which he had struggled to manage for years. A pivotal moment in his health shift came after a blunt warning from his doctor, which motivated him to prioritize his well-being. Barkley has consistently framed his goals as living longer and feeling better, rather than focusing solely on appearance. However, his journey has not been without challenges. In 2025, he revealed that a previous attempt to use a GLP-1 medication led to significant weight loss but was interrupted by supply issues, resulting in weight regain. This experience prompted him to restart his health efforts with Ro, a company collaborating with him. Barkley’s story resonates because it reflects the complexities of weight loss. His progress has been uneven, marked by periods of success and setbacks, which makes his journey relatable to many. The visibility of his transformation has also highlighted the role of GLP-1 drugs, which mimic hormones like GLP-1 and GIP to suppress appetite, slow digestion, and reduce hunger signals. These medications, when combined with lifestyle changes, can aid weight loss.#nba #charles_barkley #march_madness #mounjaro #ro
